Guardant Health, Inc. (GH)

Guardant Health Stock Forecast

Stock Price Forecast

The 20 analysts with 12-month price forecasts for Guardant Health stock have an average target of 48.4, with a low estimate of 32 and a high estimate of 60. The average target predicts an increase of 16.60% from the current stock price of 41.51.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$32	$48.4	$50	$60
Change	-22.91%	+16.60%	+20.45%	+44.54%

Analyst Ratings

The average analyst rating for Guardant Health stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	10	10	10	10	11	11
Buy	6	6	6	5	8	9
Hold	1	1	1	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	17	17	15	19	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Shannon O'Callaghan Morgan Stanley	Morgan Stanley	Buy Maintains $42 → $52	Buy	Maintains	$42 → $52	+25.27%	Mar 6, 2025
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $34 → $50	Buy	Maintains	$34 → $50	+20.45%	Feb 26, 2025
Subbu Nambi Guggenheim	Guggenheim	Strong Buy Reiterates $56	Strong Buy	Reiterates	$56	+34.91%	Feb 24, 2025
Sung Ji Nam Scotiabank	Scotiabank	Buy Maintains $47 → $52	Buy	Maintains	$47 → $52	+25.27%	Feb 24, 2025
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $42 → $60	Strong Buy	Maintains	$42 → $60	+44.54%	Feb 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

880.27M

Increased by 19.11%

from 739.02M

Revenue Next Year

1.07B

Increased by 21.44%

from 880.27M

EPS This Year

-2.92

from -3.56

EPS Next Year

-2.37

from -2.92

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	286.73M	373.65M	449.54M	563.95M	739.02M	880.27M	1.07B	1.32B
Revenue Growth	33.75%	30.32%	20.31%	25.45%	31.04%	19.11%	21.44%	23.29%
EPS	-2.60	-4.00	-6.41	-4.28	-3.56	-2.92	-2.37	-0.35
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	28	23	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	902.3M	1.1B	1.5B
Avg	880.3M	1.1B	1.3B
Low	825.6M	955.5M	1.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	22.1%	29.5%	43.0%
Avg	19.1%	21.4%	23.3%
Low	11.7%	8.5%	1.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.63	-0.92	0.63
Avg	-2.92	-2.37	-0.35
Low	-4.00	-4.40	-1.25

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.